Chronic myelogenous leukemia (CML) and depression

Chronic myelogenous leukemia (CML) is a cancer of the blood and bone marrow that frequently impacts mental health, with studies suggesting that up to 25-30% of patients experience clinically significant symptoms of depression or anxiety. While there is no direct neurological mechanism linking Chronic myelogenous leukemia (CML) to depression, the psychological burden of a chronic diagnosis, long-term medication adherence, and persistent fatigue significantly increases the risk of mood disorders.

Why is there a link between Chronic myelogenous leukemia (CML) and mental health?

The emotional impact of living with Chronic myelogenous leukemia (CML) often stems from the uncertainty of a life-long diagnosis and the side effects of tyrosine kinase inhibitors (TKIs). Patients frequently report that the "cancer survivor" label feels precarious due to the need for daily medication. The interplay between chronic fatigue—a hallmark symptom of both the disease and its treatments—and the mental exhaustion of managing a rare condition can lead to a cycle of social withdrawal and diminished quality of life.

What are the common signs of depression in CML patients?

Recognizing depression in those with Chronic myelogenous leukemia (CML) is vital, as symptoms can be masked by physical illness. Key indicators include:

• Persistent feelings of hopelessness or worthlessness regarding the future.


• Loss of interest in activities previously enjoyed.


• Significant changes in sleep patterns or appetite.


• Difficulty concentrating ("brain fog") beyond what is expected from medication side effects.


• Social isolation or withdrawal from support networks.

What therapeutic options are available for patients?

Effective management of the psychological aspects of Chronic myelogenous leukemia (CML) often involves a multi-modal approach. Cognitive Behavioral Therapy (CBT) is highly effective for restructuring thoughts around health anxiety, while Acceptance and Commitment Therapy (ACT) helps patients focus on living a meaningful life despite their diagnosis. In our community of 287 members with Chronic myelogenous leukemia (CML) at DiseaseMaps.org, many find that peer support groups provide an essential outlet for shared experiences that clinical settings cannot offer.

Next steps

• Consult your hematologist/oncologist for a referral to an onco-psychologist.


• Join the 287-member Chronic myelogenous leukemia (CML) community on DiseaseMaps.org to connect with others.


• If you are in immediate distress, call or text 988 (in the US) or contact your local emergency services immediately.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) GARD: Chronic Myelogenous Leukemia


• American Cancer Society: Emotional Side Effects of Cancer


• Leukemia & Lymphoma Society (LLS): Support Resources


• Orphanet: Chronic Myelogenous Leukemia Information